-
Study aim
-
Comparison of the effect of botulinum toxin A injection by microneedling with intradermal injection by syringe in the treatment of patients with open pores
-
Design
-
A clinical trial parallel groups, single-blind, phase 3 on 35 patients. Non-random,
-
Settings and conduct
-
Samples will be selected from patients referred to Isfahan University of Medical Sciences. Before and one month after the intervention, photography and dermoscopy are performed on both sides of the face. Photography is evaluated by two non-performing dermatologists with the Quartile improvement scale and with the Likert satisfaction scale, patients express their satisfaction.
-
Participants/Inclusion and exclusion criteria
-
Patients of both sexes, from 25 years to 60 years and with different duration of infection are selected and open pores with different intensities
Exclusion criteria:Retinoid use in the last three months, laser or peeling in the last 6 months, myasthenia gravis, pregnant and lactating women, history of allergic reaction to botulinum toxin
-
Intervention groups
-
After local anesthesia at the treatment site, botulinum toxin A is used for use at a concentration of 100 units in 2.5 ml with 9% normal saline, then in syringes of one cc with a gauge of 30, so that each syringe contains 20 units. We prepare it from botulinum. Then, on one side of the face, treated with 24-tooth microneedling to a depth of 3 to 3.5 mm, we then apply 50 units of botulinum on the site, and on the other side of the face, we inject 50 units of the solution into the dermis with a syringe.
-
Main outcome variables
-
the Quartile improvement scale، Likert satisfaction scale